Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.40 -0.09 (-2.58%)
As of: Oct 1, 2026 · 2:25 PM EDT

Galmed Pharmaceuticals (EOCN) Beginning Cash Balance (2013 - 2023)

Updated

Galmed Pharmaceuticals (EOCN) reported Beginning Cash Balance of $1.53 million for Q1 2023, up 358.3% from $333,000 a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Beginning Cash Balance (2013 - 2023) Analysis & Trends

Over the twelve months ended Mar 31, 2023, Galmed Pharmaceuticals' Beginning Cash Balance came in at $24.96 million, up 6.5% year-over-year.

  • The Q1 2023 figure ranks as the highest quarterly Beginning Cash Balance since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Galmed Pharmaceuticals 406,071.97 406,071.97 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 1.53 Mn
Mar 31, 2022 333,000.00
Mar 31, 2021 7.06 Mn
Mar 31, 2020 16.04 Mn
Mar 31, 2019 24.16 Mn
Mar 31, 2018 13.02 Mn
Mar 31, 2017 3.10 Mn
Mar 31, 2014 361,000.00
Mar 31, 2013 718,000.00
API Access

Galmed Pharmaceuticals Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=EOCN&period=max&api_key=YOUR_API_KEY